Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma

Kao, S.C-H, Griggs, K., Lee, K., Armstrong, N.ORCID: 0000-0002-4477-293X, Clarke, S., Vardy, J., van Zandwijk, N., Burn, J., McCaughan, B.C., Henderson, D.W. and Klebe, S. (2011) Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology, 43 (4). pp. 313-317.

Link to Published Version: http://dx.doi.org/10.1097/PAT.0b013e32834642da
*Subscription may be required

Abstract

AIMS:
We previously established the use of a minimal panel of antibodies as sufficient to diagnose most epithelial malignant mesothelioma (MPM). We aimed to validate this approach and investigate the utility of a D2-40 antibody.

METHODS:
A series of 80 MPM patients selected for surgery and 21 consecutive patients with pleural metastatic carcinoma were included. A minimal panel of antibodies, consisting of calretinin, BG8 and CD15, and D2-40 was investigated.

RESULTS:
There were 61 epithelial and 19 biphasic MPM as well as 12 metastatic lung, six breast (5 ductal adenocarcinomas, 1 mixed ductal/lobular adenocarcinoma), two serous papillary ovarian carcinomas and one moderately differentiated colorectal adenocarcinoma. The sensitivity of positive calretinin labelling to confirm the diagnosis of MPM was 97.5%, while the 'diagnostic sensitivities' of lack of labelling for BG8 and CD15 were 91.3% and 97.5%, respectively. The use of calretinin, BG8 and CD15 resulted in correct classification in 97.5% of all MPMs. All MPM cases investigated showed at least focal positive D2-40 labelling.

CONCLUSIONS:
We have validated the usefulness of a minimal panel of antibodies with calretinin, BG8 and CD15 as the initial step to the diagnosis of MPM. D2-40 emerged as a helpful diagnostic tool for cases where our initial approach failed to conclusively diagnose MPM.

Item Type: Journal Article
Publisher: Lippincott Williams and Wilkins
Copyright: © 2011 Royal College of Pathologists of Australasia
URI: http://researchrepository.murdoch.edu.au/id/eprint/29667
Item Control Page Item Control Page